Top Gas Utility Stocks To Invest In Right Now

Seattle Genetics, Inc. (NASDAQ:SGEN) is a big deal today, and Needham & Company says it could be the next big thing in the pharmaceutical space.

Seattle Genetics is a biotechnology company focused on the development and commercialization of monoclonal antibody-based therapies for cancer.

Its product candidate, ADCETRIS or brentuximab vedotin is approved by United States Food and Drug Administration (FDA) in two indications: the treatment of patients with Hodgkin lymphoma, and for patients with systemic anaplastic large cell lymphoma (s ALCL).

ADCETRIS is an antibody-drug conjugate, or ADC, comprising an anti-CD30 monoclonal antibody attached by a protease-cleavable linker to a microtubule disrupting agent, monomethyl auristatin E (MMAE), utilizing its technology.

Top Gas Utility Stocks To Invest In Right Now: Acura Pharmaceuticals Inc.(ACUR)

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies. Its Aversion Technology is a proprietary platform technology providing abuse deterrent features and benefits to orally administered pharmaceutical drug products containing abusable active ingredients, such as tranquillizers, stimulants, sedatives, and decongestants. The company offers OXECTA Tablets CII, which are oral formulations of oxycodone HCl for the management of acute and chronic moderate to severe pain; and Impede PSE, a pseudoephedrine hydrochloride tablet product candidate. It is also developing opioid analgesic product candidates, which would be used to relieve pain while discouraging common methods of opioid product misuse and abuse, including intravenous injection of dissolved tablets or capsules; nasal snorting of crushed tablets or capsules; and intentional swallowing of excess quantities of tablets or capsules. In addition, the company investigates and develops mechanisms to incorporate abuse deterrent features into abused and misused pharmaceutical products using its Impede Technology. Acura Pharmaceuticals, Inc. has a license, development, and commercialization agreement with King Pharmaceuticals Research and Development, Inc. to develop and commercialize certain opioid analgesic products utilizing the company?s proprietary Aversion Technology in the United States, Canada, and Mexico. The company was founded in 1935 and is based in Palatine, Illinois.

Advisors' Opinion:

• [By Rick Munarriz]

  Thursday
  Acura Pharmaceuticas (NASDAQ: ACUR  ) checks in on Thursday. Drugmakers use Acura's Aversion and Impede technologies to create abuse-deterrent treatments. In short, if an abuser tries to extract the active ingredient of a drug to heighten addictive experiences, Acura's technologies kick in to make the whole dose unusable.

• [By Sean Williams]

  ALKS-7106 for the treatment of pain has big potential as it encompasses a broad audience, but it'll need to overcome the common stigma of pain drugs with regard to easy abuse potential. According to the press release, Alkermes will be introducing newer technology that will make its opioid-based drug more resistant to abuse. It should be curious to see how well this performs as there aren't many successful abuse-resistant drugs, or companies developing those drugs for that matter. Acura Pharmaceuticals (NASDAQ: ACUR  ) , for instance, successfully brought moderate-to-severe painkiller Oxecta to market in 2011 (which it subsequently licensed to Pfizer) and a bioequivalent version of decongestant pseudoephedrine to market last year, but sales of neither drug has exactly taken off. Like with its MMF prodrug, Alkermes anticipates a mid-2014 clinical trial launch date.

Top Gas Utility Stocks To Invest In Right Now: New Jersey Resources Corp (NJR)

New Jersey Resources Corporation (NJR), incorporated in 1981, is an energy services holding company providing retail and wholesale energy services to customers in states from the Gulf Coast and Mid-Continent regions to the Appalachian and Northeast regions, the West Coast and Canada. NJR's subsidiaries and businesses include New Jersey Natural Gas (NJNG), NJR Clean Energy Ventures (NJRCEV), NJR Energy Services (NJRES) and NJR Energy Holdings Corporation (NJREH). NJNG is a local natural gas distribution company, which provides regulated retail natural gas service to approximately 500,100 residential and commercial customers in central and northern New Jersey and participates in the off-system sales and capacity release markets. NJR Clean Energy Ventures (NJRCEV) comprises the Company's Clean Energy Ventures segment and reports the results of operations and assets related to the Company's capital investments in renewable energy projects, including commercial and residential solar projects, as well as on-shore wind projects through a 19.9% interest in OwnEnergy. NJRES maintains and transacts around a portfolio of physical assets consisting of natural gas storage and transportation contracts. NJRES also provides wholesale energy management services to other energy companies and natural gas producers. NJRES comprises the Company's Energy Services segment. NJREH invests in energy-related ventures through its subsidiaries, NJNR Pipeline Company (Pipeline), which holds the Company's 5.53% ownership interest in Iroquois Gas Transmission L.P. (Iroquois) and NJR Steckman Ridge Storage Company, which holds the Company's 50% combined interest in Steckman Ridge GP, LLC and Steckman Ridge, LP (collectively, Steckman Ridge), a natural gas storage facility. Iroquois and Steckman Ridge comprise the Company's Energy Holdings segment.

NJR has retail and other operations (Retail and Other). NJR Retail Holdings (Retail Holdings) is consolidates the Company's unregulated retail operations. Retail Holdings consi! sts of wholly owned subsidiaries, including NJR Home Services (NJRHS), a company which provides heating, ventilation and cooling (HVAC) service repair and contract services to approximately 134,900 customers, as well as solar installation projects; Commercial Realty & Resources (CR&R), a company that holds and develops commercial real estate holds and develops commercial real estate, and NJR Plumbing Services (NJRPS), a company that provides plumbing repair and installation services.

NJR Energy Investments (NJREI) is an unregulated affiliate, which consolidates the Company's unregulated energy-related investments. NJREI includes the wholly owned subsidiaries, including NJR Investment, a company which makes and holds energy-related investments, through equity instruments of public companies. NJR Energy Corporation (NJR Energy), a company that invests in energy-related ventures. NJR Service an unregulated company, which provides shared administrative services, including corporate communications, financial and planning, internal audit, legal, human resources and information technology for NJR and all subsidiaries.

The Company operates within four reportable business segments: Natural Gas Distribution, Clean Energy Ventures, Energy Services and Energy Holdings. The Natural Gas Distribution segment consists of regulated energy and off-system, capacity and storage management operations. The Clean Energy Ventures segment consists of capital investments in renewable energy projects. The Energy Services segment consists of unregulated wholesale energy operations. The Energy Holdings segment consists of investments in the midstream natural gas market, such as natural gas transportation and storage facilities.

Natural Gas Distribution

NJNG provides natural gas service to approximately 500,100 customers. NJNG's service territory is in New Jersey's Monmouth and Ocean counties and parts of Burlington, Morris, Middlesex and Sussex counties. It encompasses 1,516 sq! uare mile! s, covering 105 municipalities with an population of 1.4 million people. During the fiscal year ended September 30, 2012 (fiscal 2012), NJNG added 6,704 new customers and added natural gas heat and other services to another 539 existing customers. During fiscal 2012, NJNG's gas supply portfolio consists of long-term (over seven months), winter-term (November through March) and short-term (seven months or less) contracts. During fiscal 2012 , NJNG purchased gas from approximately one hundred suppliers under contracts ranging from one day to one year and purchased over 10% of its natural gas from two suppliers. NJNG maintains agreements for firm transportation and storage capacity with several interstate pipeline companies. NJNG receives natural gas at eight citygate stations located in Middlesex, Morris and Passaic counties in New Jersey.

The pipeline companies, which provide firm contract transportation service for NJNG and supply the above pipelines are ANR Pipeline Company (ANR), Iroquois Gas Transmission L.P., Tennessee Gas Pipeline Company, Dominion Transmission Corporation (Dominion) and Columbia Gulf Transmission Company. In addition, NJNG has storage and related transportation contracts, which provide additional maximum daily deliverability to NJNG's citygate stations of 102,941 decatherm from storage fields in its Northeast market area.

Clean Energy Ventures

NJRCEV is an unregulated company, which invests, owns and operates renewable energy projects located in the State of New Jersey and owns an interest in an on-shore wind project developer. NJRCEV invests in, owns and operates residential and commercial solar installations in the State of New Jersey. As of September 30, 2012 , NJRCEV has placed a total of 35.9 megawatts of solar assets into service, including a combination of residential and commercial rooftop and ground mount solar systems.

Energy Services

NJRES provides unregulated wholesale energy services and engages in! the busi! ness of optimizing natural gas storage and transportation assets. The rights to these assets are acquired in anticipation of delivering natural gas or performing asset management activities for the Company's customers or in conjunction with identifying arbitrage opportunities that exist in the marketplace. These activities are conducted in the market areas, which include states from the Gulf Coast and Mid-Continent regions to the Appalachian and Northeast regions, the West Coast and Canada.

NJRES has developed a portfolio of natural gas storage and transportation capacity in the Gulf Coast, Mid-Continent, Appalachian and Northeast regions, the West Coast and Canada. NJRES also participates in park-and-loan transactions with pipeline and storage counterparties, where NJRES will park (store) natural gas to be redelivered to NJRES at a later date or borrow to be returned to the pipeline or storage field at a later date. NJRES has built a portfolio of customers, including local distribution companies, industrial companies, electric generators, retail aggregators, natural gas producers and other wholesale marketing companies.

Energy Holdings

Energy Holdings include investments in natural gas transportation and storage assets and is consisted of NJNR Pipeline, which consists of its 5.53% equity investment in Iroquois Gas Transmission System, which is a 412 -mile natural gas pipeline from the New York-Canadian border to Long Island, New York, and NJR Steckman Ridge Storage Company, which holds the Company's 50% equity investment in Steckman Ridge. Steckman Ridge is a partnership, jointly owned and controlled by subsidiaries of the Company and subsidiaries of Spectra Energy Corporation, which built, owns and operates a 17.7 billion cubic feet natural gas storage facility in western Pennsylvania.

Other Business Operations

Retail and Other operations consist of the unregulated affiliates, including NJRHS, which provides HVAC service, sales and ! installat! ion of appliances to approximately 134,900 customers, as well as installation of solar equipment, and CR&R, which holds and develops commercial real estate. As of September 30, 2012 , CR&R's real estate portfolio consisted of 27 acres of undeveloped land in Monmouth County, 52 acres of undeveloped land in Atlantic County, and a 56,400 -square-foot office building on five acres of land in Monmouth County. NJR Investment invests in and holds certain energy-related investments, through equity instruments of public companies. NJR Energy invests in energy-related ventures. NJR Service provides shared administrative and financial services to the Company and all its subsidiaries.

Advisors' Opinion:

• [By Laura Brodbeck]

  Earnings Releases Expected:�Nuance Communications, New Jersey Resources Corporation (NYSE: NJR), Laclede Group, Inc. (NYSE: LG)

  Economic Releases Expected:�U.S. pending home sales, Italian trade balance, Swiss employment level

• [By Garrett Cook]

  Utilities shares rose 0.26 percent in today’s trading. Top gainers in the sector included Pampa Energia SA (NYSE: PAM), up 2 percent, and New Jersey Resources (NYSE: NJR), up 1.9 percent.

• [By Seth Jayson]

  When judging a company's prospects, how quickly it turns cash outflows into cash inflows can be just as important as how much profit it's booking in the accounting fantasy world we call "earnings." This is one of the first metrics I check when I'm hunting for the market's best stocks. Today, we'll see how it applies to New Jersey Resources (NYSE: NJR  ) .

Top 5 Managed Healthcare Companies To Buy Right Now: Siebert Financial Corp.(SIEB)

Siebert Financial Corp., through its subsidiary, Muriel Siebert & Co., Inc., engages in the retail discount brokerage and investment banking operations in the United States. The company provides Internet and traditional discount brokerage and related services to retail investors; independent retail execution services; and retail customer services. It also offers various self-directed retirement accounts, for which it acts as agent on various transactions; and lends customers a portion of the market value of certain securities held in the customer?s account through its clearing agent. In addition, the company, through its other subsidiary, Siebert Woman?s Financial Network, Inc., provides products, services, and information to serve women?s financial needs. Further, Siebert Financial Corp. offers equity execution services on an agency basis, as well as equity and fixed income underwriting and investment banking services to institutional investors, and issuers of equity a nd fixed-income securities. The company provides its discount brokerage services through a broker on the telephone, through a wireless device, or via the Internet. It maintains seven retail discount brokerage offices in New York; Jersey City, New Jersey; Boca Raton, Surfside, West Palm Beach, and Naples, Florida; and Beverly Hills, California. The company was founded in 1886 and is headquartered in New York, New York.

Advisors' Opinion:

• [By Jon C. Ogg]

  Muriel Siebert, founder of Siebert Financial Corp. (NASDAQ: SIEB), passed away over the weekend. Many new investors may not know her nor may they know just how important and influential she was on Wall Street and in the financial services industries. Ms. Siebert died at the age of 80 years old, and we wanted to list some of her accomplishments that have led to at least more equality among women in what had been a men-only club before she came on the stage.

Top Gas Utility Stocks To Invest In Right Now: Banca Monte dei Paschi di Siena SpA (BMPS)

Banca Monte dei Paschi di Siena SpA is an Italy-based company engaged in the banking sector. It provides traditional banking services, asset management and private banking, including life insurance, pension funds and investment trusts. It operates though three business segments. The Retail Banking segment covers consumer lending, insurance, provision of financial and non-financial services to retail customers, wealth management, tax planning, financial advisory and planning for private customers. The Corporate Banking division oversees the Group's business strategies targeted to small and medium enterprises, institutions and large corporate for which it offers leasing, factoring, lending and financial products, among others. The Corporate Center segment includes the cancellation of intergroup entries, treasure, governance and support functions. In January 2014, the Company completed the sale of its entire shareholding in Sorin SpA, equal to approximately 5.7%. Advisors' Opinion:

• [By Corinne Gretler]

  Kesko Oyj, Finland�� biggest publicly traded retailer, rallied 9 percent. Banca Monte dei Paschi di Siena SpA (BMPS) added 2 percent as Italy�� third-largest lender set out a plan to return to profit after cutting costs and raising capital as part of its restructuring plan. Speedy Hire Plc sank the most since 2009 after the construction-equipment leasing company said it found evidence of false accounting at one of its units.

Top Gas Utility Stocks To Invest In Right Now: Air Industries Group Inc (AIRI)

Air Industries Group, Inc. (AIRI), incorporated on January 13, 2006, is an aerospace and defense company. The Company designs and manufactures structural parts and assemblies that focus on flight safety, including landing gear, arresting gear, engine mounts, flight controls, throttle quadrants and other components. It also provides sheet metal fabrication of aerostructures, tube bending and welding services. AIRI�� products are deployed on a range of military and commercial aircraft, including Sikorsky's UH-60 Blackhawk helicopter, Lockheed Martin's F-35 Joint Strike Fighter, Northrop Grumman's E2D Hawkeye, Boeing's 777, Airbus' 380 commercial airliners, and the US Navy F-18 and USAF F-16 fighter aircraft. On July 1, 2013, Air Industries Group Inc announced that it has acquired certain assets and the business of Decimal Industries (Decimal) of Copiague, Long Island, New York. On June 20, 2012, the Company, through a newly created subsidiary, Nassau Tool Works, Inc. (NTW), acquired from an unrelated company formerly known as Nassau Tool Works, Inc. (Old Nassau Tool) and its shareholders (the NTW Sellers) all of the assets of Old Nassau Tool. In November 2013, the Company announced that it has acquired Miller Stuart Inc of Hauppauge, Long Island, New York.

Air Industries Machining Corp.

AIM manufactures aircraft structural parts and assemblies principally for prime defense contractors in the defense/aerospace industry, including, Boeing, Goodrich Landing Gear, Sikorsky, Lockheed Martin, and Northrop Grumman. During the year ended December 31, 2012, approximately 90% of AIM's revenues were derived from sales of parts and assemblies for military applications. AIM's parts are installed onboard Sikorsky's U/MH - 60M/S Helicopters, known as The BlackHawk, Lockheed�� F35 Joint Strike Fighter (JSF), Northrop Grumman�� E2-C/D Hawkeye, the Airbus A-380 Super Jumbo airliner, and the C-17 Globemaster.

AIM is also a manufacturer of mechanical and electro-mechanical suba! ssemblies and an engineering integrator. As of December 31, 2012, AIM produced over 2,400 individual products (SKU's) that are assembled into electromechanical devices, mixer (primary flight control) assemblies, rotor-hub components for Blackhawk helicopters, arresting gear for the E2C/D Hawkeye, C2A Greyhound and United States Navy Fighters, vibration absorbing assemblies for Sikorsky helicopters, landing gear components for the F-35 Joint Strike Fighter (JSF), and many other subassembly packages.

Welding Metallurgy, Inc.

Welding Metallurgy, Inc. (WMI) provides specialty welding services and metal fabrications to the defense and commercial aerospace industry. Its customers include GKN Corporation, Sikorsky, Lockheed Martin, Boeing and Northrop Grumman. WMI�� product and service offerings include tube bending and metal fabrications of aircraft structures. WMI�� services and products are principally provided to prime contractors, aerospace engine manufacturers and to other subcontractors to aerospace manufacturers throughout the United States. Welding Metallurgy is a primary supplier on the Northrop Grumman E-2 C/D Hawkeye Program producing approximately 300 different parts annually. During 2012, nearly 100% of WMI�� revenues were derived from sales of parts and assemblies for military applications. WMI produces the inlet housing and the auxiliary long and short beams for the Sikorsky BlackHawk helicopter and various welded door and panel assemblies for the Boeing CH-47 Chinook Helicopter. WMI also provides environmental tubing to Lockheed for the F-35 Joint Strike Fighter.

Nassau Tool Works, Inc.

NTW�� principal business is the fabrication and assembly of landing gear components and complete landing gear for fighter aircraft for the United States and foreign governments. NTW also performs sub-contract machining for other aerospace manufacturers, including Air Industries. NTW is a manufacturer of complete landing gear and landing gear components! for the ! F-16 Fighting Falcon and F-18 Hornet aircraft of the United States Air Force and Navy. In addition NTW specializes in deep hole gun-drilling and trepanning and performs sub-contract machining services for prime contractors in the defense and aerospace industries.

The Company competes with Sterling Machine, Stellex Aerospace, Triumph Aerospace Group, Heroux Aerospace and Magellan Corporation.

Advisors' Opinion:

• [By Diane Alter]

  Dividend Stocks That Increased Payout in September

  Accenture plc (NYSE: ACN) announced a 14.8%, or $0.12 per share, increase to its semiannual dividend. The management consulting firm will now pay a semiannual dividend of $0.93. Shares yield 2.53%. Agruim Inc. (NYSE: AGU) boosted its dividend by $1.00 per share to a total dividend of $3.00 on an annualized basis. Shares of the global retailer of agricultural products now sprout a 3.54% yield. Air Industries Group Inc. (NYSE: AIRI) doubled its dividend to $0.125 per share. The maker of airplane and helicopter parts now floats a lofty yield of 6.6%. Alexandria Real Estate Equities Inc. (NYSE: ARE) upped its dividend 4.6% to $0.68 per quarter for a yield of 4.21%. Banner Corp. (Nasdaq: BANR) boosted its quarterly dividend 25% to $0.15 per share. The parent company of Banner and Islander Bank serves the Pacific Northwest region. Brady Corp. (NYSE: BRC) lifted its quarterly dividend 2.6% to $0.78 per share. It was the 28th straight dividend increase from the identification solutions company. Shares yield 2.57%. Campbell Soup Co. (NSE: CPB) raised its quarterly dividend to $0.31 per share, up from $0.29. The company last raised its dividend in November 2010. Shares yield a hearty 3.06%. CLARCOR Inc. (NYSE: CLC) raised its quarterly dividend 26% to $0.17 per share. It's the largest percentage increase from the Tennessee-based diversified marketer of mobile filtration and packaging products in the last 20 years, and it continues the company's consecutive streak of increasing dividends for the last 30 years. Franklin Resources Inc. (NYSE: BEN) boosted its quarterly dividend 2.6% to $0.10 per share. Frisch's Restaurants Inc. (NYSE: FRS) increased its quarterly dividend 12.5% to $0.18. Shares yield 3.10% The Goodyear Tire & Rubber Company (NYSE: GT), in a move that suggests good times are ahead, reinstated its dividend at $0.05 per share. Good
• [By Louis Navellier]

  Air Industries (AIRI) is an example of a company with great fundamentals that also pays a solid dividend right now. Air Industries makes flight-critical products including flight safety parts, landing gear and components, arresting gear, flight controls, sheet metal fabrications and ground support equipment. At the current price AIRI stock is yielding 6.32% after Air Industries raised the dividend back in March.

• [By Dividends4Life]

  Air Industries Group Inc. (AIRI), an aerospace and defense company, designs and manufactures structural parts and assemblies that focus on flight safety. Sept. 17, the company increased its quarterly dividend 100% to $0.125 per share. The dividend is is payable Oct. 15, 2013 to shareholders of record as of the close of business on Sept. 30, 2013. The yield based on the new payout is 6.9%.

Top Gas Utility Stocks To Invest In Right Now: NewLink Genetics Corp (NLNK)

NewLink Genetics Corporation (NewLink), incorporated on June 4, 1999, is a development-stage company. The Company is a biopharmaceutical company focused on discovering, developing and commercializing immunotherapeutic products for cancer treatment. Its portfolio includes biologic and small-molecule immunotherapy product candidates focused to treat a range of oncology indications. Its product candidate, HyperAcute Pancreas cancer immunotherapy (HyperAcute Pancreas), is being studied in a Phase-III clinical trial in surgically-resected pancreatic cancer patients that is being performed under a Special Protocol Assessment (SPA), with the United States Food and Drug Administration (FDA). It has three additional product candidates in clinical development, including its HyperAcute Lung cancer immunotherapy (HyperAcute Lung), which is being studied in a Phase-I/II clinical trial conducted at the National Cancer Institute (NCI), and its HyperAcute Melanoma cancer immunotherapy (HyperAcute Melanoma), which is being studied in an investigator-initiated Phase-II clinical trial.

The Company�� HyperAcute product candidates are based on its HyperAcute immunotherapy technology, which is designed to stimulate the human immune system. It is also conducting small-molecule based research and development to produce new drugs capable of breaking the immune system's tolerance to cancer through inhibition of the indoleamine-(2,3)-dioxygenase (IDO), pathway. It is engaged in the study of IDO pathway inhibitor product candidate, d-1-methyltryptophan (D-1MT), in collaboration with the NCI, in two Phase 1B/II clinical trials.

HyperAcute Cancer Immunotherapy Product Candidates

In May 2010, the Company initiated Phase-III clinical trial for HyperAcute Pancreas. Its second product candidate, HyperAcute Lung, is in a Phase I/II clinical trial that is enrolled with 54 patients for the treatment of refractory, recurrent or metastatic nonresectable non-small cell lung cancer (NSCLC). Its Hyper! Acute Melanoma product candidate is being studied in an investigator-initiated, fully enrolled 25 patient Phase-II clinical trial for the treatment of advanced melanoma.

HyperAcute Cancer Immunotherapy Technology

The Company�� HyperAcute immunotherapies operate by exploiting a natural barrier present in humans that protects against infection being transmitted from other mammals. This barrier is related to the enzyme, alpha (1,3) galactosyl transferase, which is expressed in the cells of lower mammals. The presence of this enzyme results in the expression of a non-human form of carbohydrate called alpha (1,3) galactosyl carbohydrates (a-Gal), on the surface of affected cells. Its HyperAcute immunotherapy product candidates are composed of irradiated, live, allogeneic human cancer cells modified to express the gene that makes a-Gal epitopes. This exposure to a-Gal stimulates the human immune system to attack and destroy the immunotherapy cells on, which a-Gal is present by activating complement.

IDO Pathway Inhibitor Product Candidate

The Company is developing D-1MT, a small-molecule, orally bioavailable product candidate designed to inhibit the IDO pathway. In preclinical models, IDO pathway inhibitors have shown anti-tumor effects in combination with radiotherapy, chemotherapy, targeted therapy or immunotherapy. Through its collaboration with the NCI, it is studying D-1MT in two Phase 1B/II safety and efficacy clinical trials in various chemotherapy and immunotherapy combinations. One clinical trial combines D-1MT with an Ad-p53 autologous dendritic cell vaccine for solid malignancies with p53 mutations, such as lung, breast and colon cancers. The other clinical trial involves the combined use of D-1MT and Taxotere for patients with advanced stage solid tumors, for which Taxotere is the standard-of-care treatment, such as metastatic breast, prostate, ovarian and lung cancers.

Advisors' Opinion:

• [By Jake L'Ecuyer]

  In trading on Thursday, healthcare shares were relative laggards, down on the day by about 0.64 percent. Top decliners in the sector included Sunesis Pharmaceuticals (NASDAQ: SNSS), off 5.6 percent, and NewLink Genetics (NASDAQ: NLNK), down 6.3 percent.

• [By Jayson Derrick]

  NewLink Genetics (NASDAQ: NLNK) announced that it will discontinue the phase 3 IMPRESS clinical trial of algenpantucel-L for patients with pancreatic cancer. The company intends to regroup and ��athering additional, more mature data in support of our mission to provide improved treatment options for patients with pancreatic cancer.��Shares fell 16.20 percent, closing at $31.60.